These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32666706)

  • 41. Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series.
    Xiong A; Yang G; Song Z; Xiong C; Liu D; Shuai Y; He L; Zhang L; Guo Z; Shuai S
    Ther Adv Neurol Disord; 2021; 14():1756286421998918. PubMed ID: 33786066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mitophagy in three cases of immune-mediated necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: ultrastructural and immunohistochemical studies.
    Matsubara S; Bokuda K; Asano Y; Morishima R; Sugaya K; Miyamoto K; Koide R; Komori T; Suzuki S; Nishino I
    Neuromuscul Disord; 2018 Mar; 28(3):283-288. PubMed ID: 29402601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
    Tiniakou E; Pinal-Fernandez I; Lloyd TE; Albayda J; Paik J; Werner JL; Parks CA; Casciola-Rosen L; Christopher-Stine L; Mammen AL
    Rheumatology (Oxford); 2017 May; 56(5):787-794. PubMed ID: 28096458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Statin-induced anti-HMGCR antibody-related immune-mediated necrotising myositis achieving complete remission with rituximab.
    Zhang W; Prince HM; Reardon K
    BMJ Case Rep; 2019 Dec; 12(11):. PubMed ID: 31791994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-HMGCR antibodies and asymptomatic hyperCKemia. A case report.
    Torri F; Ali G; Chico L; Siciliano G; Ricci G
    Acta Myol; 2021 Jun; 40(2):105-108. PubMed ID: 34355128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
    Shovman O; Gilburd B; Chayat C; Lazar AD; Amital H; Blank M; Bentow C; Mahler M; Shoenfeld Y
    Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy.
    Kassardjian CD; Lennon VA; Alfugham NB; Mahler M; Milone M
    JAMA Neurol; 2015 Sep; 72(9):996-1003. PubMed ID: 26192196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Immune-mediated necrotizing myopathy associated with antibodies to hydroxy-methyl-glutaryl-coenzyme A reductase].
    Hinschberger O; Lohmann C; Lannes B; Martzolff L; Vo BD; Jaeger-Bizet F; Ciobanu E; Kieffer P
    Rev Med Interne; 2014 Aug; 35(8):546-9. PubMed ID: 23910221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-HMGCR immune-mediated necrotising myopathy: Addressing the remaining issues.
    Khoo T; Chinoy H
    Autoimmun Rev; 2023 Dec; 22(12):103468. PubMed ID: 37884200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pediatric immune-mediated necrotizing myopathy.
    Wang CH; Liang WC
    Front Neurol; 2023; 14():1123380. PubMed ID: 37021281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment and outcomes in anti-HMG-CoA reductase-associated immune-mediated necrotising myopathy. Comparative analysis of a single-centre cohort and published data.
    Rademacher JG; Glaubitz S; Zechel S; Oettler M; Tampe B; Schmidt J; Korsten P
    Clin Exp Rheumatol; 2022 Feb; 40(2):320-328. PubMed ID: 35225222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statin-Induced Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (Anti-HMGCR) Myopathy.
    Ghazal F; Zur M; Silver A
    Cureus; 2023 Jan; 15(1):e34121. PubMed ID: 36843759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Case of Anti-Single Recognition Particle-Mediated Necrotizing Myopathy After Influenza Vaccination.
    Mamarabadi M; Baisre A; Leitch M; Hsu V; Kanduri JS; Chen S
    J Clin Neuromuscul Dis; 2018 Jun; 19(4):211-216. PubMed ID: 29794576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffuse Large B-cell Lymphoma Complicated with Anti-3-hydroxy-3-methylglutaryl-Coenzyme A Reductase Immune-mediated Necrotizing Myopathy: A Case Report.
    Tokunaga Y; Akiyama M; Nakano K; Konaka K; Taguchi A; Maeda T; Sato R; Kanda T; Nakamura Y; Yujiri T; Ohta Y
    Intern Med; 2024 Jul; ():. PubMed ID: 38987186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical and pathological characteristics of immune mediated necrotizing myopathy].
    Yang HX; Tian XL; Jiang W; Li WL; Liu QY; Peng QL; Wang GC; Lu X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):989-995. PubMed ID: 31848492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Necrotizing Autoimmune myopathy: A case report on statin induced rhabdomyolysis requiring immunosuppressive therapy.
    Kunwar S; Parekh JD; Chilukuri RS; Andukuri VA
    Drug Discov Ther; 2018; 12(5):315-317. PubMed ID: 30464165
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiological and genetic features of anti-3‑hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review.
    Prieto-Peña D; Ocejo-Vinyals JG; Mazariegos-Cano J; Pelayo-Negro AL; Remuzgo-Martínez S; Genre F; García-Dorta A; Renuncio-García M; Martínez-Taboada VM; García-Ibarbia C; Sánchez-Martín J; López-Hoyos M; Blanco R; González-Gay MA; Hernández JL
    Eur J Intern Med; 2022 Jul; 101():86-92. PubMed ID: 35487805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
    Allenbach Y; Benveniste O; Stenzel W; Boyer O
    Nat Rev Rheumatol; 2020 Dec; 16(12):689-701. PubMed ID: 33093664
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A young female case of asymptomatic immune-mediated necrotizing myopathy: a potential diagnostic option of antibody testing for rhabdomyolysis.
    Sasaki R; Yunoki T; Nakano Y; Fukui Y; Takemoto M; Morihara R; Katsuyama E; Nishino I; Yamashita T
    Neuromuscul Disord; 2023 Feb; 33(2):183-186. PubMed ID: 36652875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-HMGCR (Hydroxy-3-Methylglutaryl-CoA Reductase) Myopathy: A Rare Cause of Proximal Muscle Weakness.
    Fink NS; Abubshait L; Deshisky A
    Cureus; 2024 May; 16(5):e61094. PubMed ID: 38919212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.